RxSight shareholders re-elect three Class II directors, approve charter amendment, ratify auditor

RxSight, Inc.

Re-elected William J. Link, Robert Warner, and Shweta Singh Maniar as Class II directors with 24.2M, 21.9M, and 21.2M votes for, respectively.
Approved certificate of incorporation amendment for officer exculpation under Delaware law: 22.2M for, 2.2M against.
Ratified Ernst & Young as independent auditor for FY2023: 29.5M for, 3,150 against.
87.2% of outstanding shares (29.6M of 33.97M) represented at the June 1, 2023 Annual Meeting.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

RxSight, Inc. shareholders approved Election of Three Class II Directors at the 2023-06-01 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-01

Exact text from the filing

1. Election of Three Class II Directors. The following nominees were re-elected by the holders of our common stock to serve as our Class II directors to hold office until our 2026 annual meeting of stockholders and until their successors have been duly elected and qualified: Nominee For Withhold Broker Non-Votes William J. Link, Ph.D. 24,161,853 253,009 5,195,070 Robert Warner 21,883,075 2,531,787 5,195,070 Shweta Singh Maniar 21,198,960 2,215,902 5,195,070

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

RxSight, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-01 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-01

Exact text from the filing

3. Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified based on the following results of voting: For Against Abstain Broker Non-Votes 29,491,614 3,150 115,168 —

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

RxSight, Inc. shareholders approved Amendment of the Company's certificate of incorporation to reflect new Delaware law provisions regarding officer exculpation at the 2023-06-01 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2023-06-01

Exact text from the filing

2. Amendment of the Company's certificate of incorporation to reflect new Delaware law provisions regarding officer exculpation. The amendment of the Company's certificate of incorporation to reflect new Delaware law provisions regarding officer exculpation was approved based on the following results of voting: For Against Abstain Broker Non-Votes 22,214,405 2,173,831 26,626 5,195,070

View on SEC.gov

Browse all shareholder votes →

RxSight, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-025787

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.